CYP46A1 — Cholesterol 24-Hydroxylase

Overview

Cyp46A1 — Cholesterol 24 Hydroxylase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Pathway Diagram

flowchart TD
    CYP46A1["CYP46A1"]
    style CYP46A1 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    _middle_temporal_gyrus__spiny_["'middle temporal gyrus'_spiny_L3"]
    CYP46A1 -->|"expressed in"| _middle_temporal_gyrus__spiny_
    _middle_temporal_gyrus__aspiny["'middle temporal gyrus'_aspiny_L3"]
    CYP46A1 -->|"expressed in"| _middle_temporal_gyrus__aspiny
    CYP46A1 -->|"expressed in"| _middle_temporal_gyrus__spiny_
    neurodegeneration["neurodegeneration"]
    CYP46A1 -->|"associated with"| neurodegeneration
    TAU["TAU"]
    CYP46A1 -->|"associated with"| TAU
    DEMENTIA["DEMENTIA"]
    CYP46A1 -->|"associated with"| DEMENTIA
    MYELIN["MYELIN"]
    CYP46A1 -->|"associated with"| MYELIN
    PARKINSON["PARKINSON"]
    CYP46A1 -->|"associated with"| PARKINSON
    h_2600483e["h-2600483e"]
    h_2600483e -->|"therapeutic target"| CYP46A1
    h_2600483e -->|"targets gene"| CYP46A1
    h_2600483e -->|"targets"| CYP46A1
    style _middle_temporal_gyrus__spiny_ fill:#888,stroke:#4fc3f7,color:#e0e0e0
    style _middle_temporal_gyrus__aspiny fill:#888,stroke:#4fc3f7,color:#e0e0e0
    style neurodegeneration fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
    style TAU fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
    style DEMENTIA fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
    style MYELIN fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
    style PARKINSON fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0
    style h_2600483e fill:#888,stroke:#4fc3f7,color:#e0e0e0

Introduction

Cyp46A1 — Cholesterol 24 Hydroxylase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. ^{1NCBI Gene - Gene databaseOpen reference}

The CYP46A1 gene encodes cholesterol 24-hydroxylase, a enzyme expressed primarily in neurons of the brain that catalyzes the conversion of cholesterol to 24-hydroxycholesterol. This enzyme is the key player in cholesterol elimination from the brain, as 24-hydroxycholesterol can cross the blood-brain barrier for peripheral clearance. Genetic variations in CYP46A1 have been associated with an increased risk of Alzheimer’s disease, making it an important therapeutic target.

Gene Overview

Function

CYP46A1 plays a critical role in cholesterol metabolism, which is intimately connected to Alzheimer’s disease pathogenesis through multiple mechanisms:

Role in Cholesterol Homeostasis

• Regulates cholesterol biosynthesis and uptake

• Maintains neuronal membrane composition

• Influences synaptic function and plasticity

• Modulates amyloid precursor protein (APP) processing

Brain Cholesterol Metabolism

The brain contains approximately 25% of the body’s cholesterol but is isolated from peripheral cholesterol by the blood-brain barrier. Key mechanisms include:

• Local cholesterol synthesis in neurons and glia

• CYP46A1-mediated 24-hydroxylation for efflux

• ApoE-mediated cholesterol transport

• LDLR-mediated uptake

Disease Associations

Alzheimer’s Disease

Other Associated Conditions

Therapeutic Implications

Statins and AD

HMGCR inhibitors (statins) have been studied extensively in AD:

• Observational studies suggest reduced AD risk with statin use

• Clinical trials have shown mixed results

• Lipophilic statins may be more effective due to brain penetration

Future Directions

• CYP46A1 activation for enhanced cholesterol efflux

• SREBP-2 modulators

• LDLR-targeted therapies

• Combination approaches targeting multiple pathways

Expression

The CYP46A1 gene shows distinct expression patterns:

• Brain: Primary expression in neurons and astrocytes

• Liver: High expression for systemic cholesterol regulation

• Peripheral tissues: Variable expression

Key Publications

1. Bjorkhem I, et al. (2006). “Cholesterol 24-hydroxylase: an enzyme of cholesterol elimination in the brain.” Biochemical and Biophysical Research Communications. DOI:10.1016/j.bbrc.2006.02.114

2. Carter CJ. (2007). “Alzheimer’s disease: APP, gamma-secretase, APOE, LDLR, and cholesterol: a pathological triad?” Journal of Neurochemistry. DOI:10.1111/j.1471-4159.2007.04586.x

Overview

Cyp46A1 — Cholesterol 24 Hydroxylase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Cyp46A1 — Cholesterol 24 Hydroxylase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data

Cross-References

• Cholesterol Metabolism in AD

• APOE Gene - Apolipoprotein E

• Lipid Rafts and Neurodegeneration

• Amyloid Precursor Protein

See Also

• Genes/Cyp46A1 — This page